Tammy Finnigan speaking at SCOPE Europe 2019 – Are you going?

Tammy Finnigan, TRI COO will be speaking at SCOPE Europe in September. Speaking on the first day in the Risk-Based Monitoring strand, she’ll sharing her knowledge and insights on critical topics such as: risk-based monitoring in E6 and E8; the impact RBM has on the changing role of the CRA; and industry collaboration around risks. We’ll be on booth…

Read More

COO’s Blog

May 2019 In this video blog, Tammy talks about how Centralized Monitoring won’t solve all your Quality Management issues, the changing role of the CRA because of RBM, the first readout of the E8 (R1) guidance and much more… What’s new and exciting in the Sector? April 15th 2019: We’re finally starting to get a readout from some of…

Read More

TRI Webinar Channel

Go to our new webinar channel Over the last few years we’ve run over 25 different webinars to over 1,000 people. We often get requests for the recordings, so now we’ve made it easy for anyone and everyone to watch them.  There is a treasure trove of useful information, industry insights and great advice in there, so go ahead…

Read More

FDA RBM Q&A Guidance for Industry

In March 2019 the FDA released their RBM Q&A Guidance for Industry. If you haven’t read it yet, the link is below, it makes for some interesting reading. The focus of this guidance is to provide further clarification and suggestions on how best to implement risk based approaches to monitoring. Interestingly the guidance focuses very heavily on the risk…

Read More

Phil M’Caw new TRI CFO

Phil M’Caw has been appointed as the new Chief Financial Officer of TRI. Phil has over 25 years of hands-on experience of financial and commercial management in several sectors with growth businesses having international footprints. He trained as Chartered Accountant with KPMG London before moving into management consultancy with KPMG and then into roles in industry. He has worked…

Read More

Mike Lewis announced as Chair of TRI

Mike is Chair of 4 public and private healthcare companies and has 30 years global Health industry experience having previously held senior roles at Align Technology (Amsterdam), Boston Scientific (Paris), C.R. Bard (USA), Sybron (Switzerland) and Becton Dickinson (UK) and was President of Gambro (Sweden) leading the £3bn buyout. Having spent 22 of the last 25 years living and…

Read More

TRI raises multi-million growth funding

TRI raises multi-million growth funding from Octopus Investments to expand its Risk-Based Monitoring platform for clinical trials 15th October 2018, LONDON, UK – TRI, a leading global provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has completed a growth capital fundraise to accelerate development of its core technology platform, OPRA and expand its international presence. Founded in 2014,…

Read More

R2 survey results June 2018

Only 12% of companies reporting R2 readiness In June this year we conducted an industry survey on ICH E6 (R2) readiness, and had over 100 responses.  Only 12 % said they have completed their readiness programs.  Even more surprising, 27% of respondents said they haven’t even started yet. Given the adoption of R2 by EMA, FDA and Health Canada…

Read More

Webinar: OPRA – technology that makes quality management and R2 compliance simple

June 21, 10:00am EDT / 3:00pm BST Free webinar: OPRA – making quality management and R2 compliance simple       This webinar showcases TRI’s OPRA technology platform.  Learn how OPRA supports central monitoring, RBM, quality oversight and reporting. Understand what’s new in the latest release of OPRA and what’s upcoming in the next release.    To Register, click…

Read More

Webinar: A practical guide managing protocol risks

June 14, 10:00am EDT / 3:00pm BST Free Webinar: R2 readiness – A practical guide to protocol risk assessment, evaluation and implementing risk controls. This webinar is designed to help anyone planning to conduct protocol risk assessment and develop a quality management plan as part of ICH E6 (R2) compliance. The session will describe the regulatory context from ICH…

Read More

Webinar: What you need to know about R2

June 7, 10:00am EDT / 3:00pm BST Everything you need to know about the key ICH GCP E6 (R2) changes. It’s for anyone wanting know what R2 is, why it has been implemented and how it will impact your company. The impact of ICH E6 (R2) on any company running clinical trials is going to be significant. With most…

Read More

eLearning R2 Awareness Training

The fastest and most cost effective way to understand what ICH E6 (R2) is, why it is so important, and what it means to your organization. This 90-minute course is available as a self-serve eLearning package, or an instructor led webinar. The course is targeted at individuals within Sponsor organizations and CROs that are involved in the design, conduct…

Read More

Datatrial and TRI announce tech tie up

Datatrial and TRI announce tech tie up The clinical trials industry is going through the biggest regulatory change in two decades, forcing companies that run trials to adopt a data driven approach and focus more on quality risk management. Dr Emma Banks, CEO of Datatrial based in northeast England said: “We are delighted to announce Datatrial’s technology partnership with TRI. We…

Read More

TRI nominated for the 2016 Metrics Champion Consortium(MCC) Champion award

TRI has been selected as a member of this year’s group of MCC Champions – a special honor bestowed upon individuals who made significant contributions in 2016 to advancing the MCC mission to improve the efficiency, quality and effectiveness of clinical trials. As the Metrics Champion Consortium (MCC) passes its ten year anniversary, the original mission has stayed the…

Read More